跳至主要内容
临床试验/NL-OMON41443
NL-OMON41443已完成不适用

Blood-brain barrier permeability in cerebral small vessel disease: a dynamic contrast-enhanced MRI study. - Blood-brain barrier in cerebral small vessel disease

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • LACI patients: A first-ever acute lacunar stroke ;Mild VCI due to cSVD:
  • - Subjective complaints of cognitive functioning and objective cognitive impairment in at least 1 cognitive domain on cognitive testing, and
  • - A Clinical Dementia Rating <=1 and a MMSE >=20 (i.e. no dementia), and
  • - Vascular lesions on brain MRI (lacunar infarts, white matter lesions, deep microbleeds) that suggest a link between the cognitive deficit and cSVD.;Healthy control subjects: Healthy control subjects are included from the general population and matched to the LACI and mild VCI patients according to gender and age.

排除标准

  • Exclusion criteria for all subjects:
  • Cerebrovascular abnormalities in history
  • o Ischemic stroke
  • o Haemorrhagic stroke (subarachnoid or intracerebral)
  • Contra indications for MRI/DCE-MRI
  • o Heart valve prosthesis
  • o Pacemaker
  • o Intracerebral clips (aneurysm)
  • o Intra-ocular metal pieces
  • o Cochlear implant
  • o Claustrophobia
  • o Poor kidney function (GFR<30ml/min)
  • o Previous allergic reaction to contrast agent (gadobutrol)
  • Psychiatric disorders associated with (temporarily) cognitive decline (e.g. depression, psychosis);Group specific exclusion criteria:
  • Lacunar stroke
  • - Potential cardiac embolic source (e.g. atrial fibrillation)
  • - Stenosis of >=50% of one or both internal carotid arteries.
  • Mild cognitive impairment due to cSVD
  • - Clinical and/or subclinical cortical events
  • - Other causes for cognitive impairment (e.g. Alzheimers Disease)
  • Healthy subjects
  • - Clinically overt cardiovascular diseases
  • - Clinically overt cerebrovascular diseases
  • - Disease of the central nervous system (e.g. Multiple Sclerosis, brain tumor/metastasis)
  • - Extensive structural lesions on MRI associated with cSVD
  • - Cognitive impairment (i.e. objective and/or subjective cognitive deficits).

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验